The DOI matches its Crossref record.
Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice
Open accessAbstract
PURPOSE: Acute, severe asthma exacerbations can be difficult to predict and thus prevent. Patients who have frequent exacerbations are of particular concern. Practical exacerbation predictors are needed for these patients in the primary-care setting. PATIENTS AND METHODS: Medical records of 130,547 asthma patients aged 12-80 years from the UK Optimum Patient Care Research Database and Clinical Practice Research Datalink, 1990-2013, were examined for 1 year before (baseline) and 1 year after (outcome) their most recent blood eosinophil count. Baseline variables predictive (P<0.05) of exacerbation in the outcome year were compared between patients who had two or more exacerbations and those who had no exacerbation or only one exacerbation, using uni- and multivariable logistic regression models. Exacerbation was defined as asthma-related hospital attendance/admission (emergency or inpatient) or acute oral corticosteroid (OCS) course. RESULTS: Blood eosinophil count >400/µL (versus ≤400/µL) increased the likelihood of two or more exacerbations >1.4-fold (odds ratio [OR]: 1.48 (95% confidence interval [CI]: 1.39, 1.58); P<0.001). Variables that significantly increased the odds by up to 1.4-fold included increasing age (per year), female gender (versus male), being overweight or obese (versus normal body mass index), being a smoker (versus nonsmoker), having anxiety/depression, diabetes, eczema, gastroesophageal reflux disease, or rhinitis, and prescription for acetaminophen or nonsteroidal anti-inflammatory drugs. Compared with treatment at British Thoracic Society step 2 (daily controller ± reliever), treatment at step 0 (none) or 1 (as-needed reliever) increased the odds by 1.2- and 1.6-fold, respectively, and treatment at step 3, 4, or 5 increased the odds by 1.3-, 1.9-, or 3.1-fold, respectively (all P<0.05). Acute OCS use was the single best predictor of two or more exacerbations. Even one course increased the odds by more than threefold (OR: 3.75 [95% CI: 3.50, 4.01]; P<0.001), and three or more courses increased the odds by >25-fold (OR: 25.7 [95% CI: 23.9, 27.6]; P<0.001). CONCLUSION: Blood eosinophil count and several other variables routinely available in patient records may be used to predict frequent asthma exacerbations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bleecker, E. R., FitzGerald, J. M., Chanez, P., Papi, A., Weinstein, S. F., Barker, P., Sproule, S., Gilmartin, G., Aurivillius, M., Werkström, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31324-1 · Cited by 1,406
Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management
Bleecker, E. R., Menzies-Gow, A. N., Price, D. B., Bourdin, A., Sweet, S., Martin, A. L., Alacqua, M., & Tran, T. N. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201904-0903so · Cited by 380
Self-citationInhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes
Price, D. B., Román-Rodríguez, M., McQueen, R. B., Bosnic-Anticevich, S., Carter, V., Gruffydd-Jones, K., Haughney, J., Henrichsen, S., Hutton, C., Infantino, A., et al. (2017) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.01.004 · Cited by 327
Self-citationFitzGerald, J. M., Bleecker, E. R., Menzies-Gow, A., Zangrilli, J. G., Hirsch, I., Metcalfe, P., Newbold, P., & Goldman, M. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30344-2 · Cited by 318
Busse, W. W., Bleecker, E. R., FitzGerald, J. M., Ferguson, G. T., Barker, P., Sproule, S., Olsson, R. F., Martin, U. J., Goldman, M., Yañez, A., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30406-5 · Cited by 314
Suruki, R. Y., Daugherty, J. B., Boudiaf, N., & Albers, F. C. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0409-3 · Cited by 277
on behalf of the LIAISON Study Group, Braido, F., Brusselle, G., Guastalla, D., Ingrassia, E., Nicolini, G., Price, D., Roche, N., Soriano, J. B., & Worth, H. (2016) · Respiratory Research · doi:10.1186/s12931-016-0374-z · Cited by 152
Weatherburn, C. J., Guthrie, B., Mercer, S. W., & Morales, D. R. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.12971 · Cited by 68
“Reflux is potentially an important comorbidity associated with an increased risk of asthma exacerbations due to direct airway contact with gastric acid triggering a vasovagal reflex and bronchospasm.(25) An association with hypertension may also be related to the use of chronic inhaled beta2-agonist stimulants or in p…”
BackgroundAsthma in the Precision Medicine Era: Biologics and Probiotics
Chiu, C.-J., & Huang, M.-T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094528 · Cited by 60
Edwards, M. R., Saglani, S., Schwarze, J., Skevaki, C., Smith, J. A., Ainsworth, B., Almond, M., Andreakos, E., Belvisi, M. G., Chung, K. F., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02448-2016 · Cited by 55
Self-citationLong-term predictors of anxiety and depression in adult patients with asthma
Labor, M., Labor, S., Jurić, I., Fijačko, V., Popović Grle, S., & Plavec, D. (2017) · Wiener klinische Wochenschrift · doi:10.1007/s00508-017-1203-1 · Cited by 11
Metadata
- Authors
- King, C., Price, D., Wilson, A., Chisholm, A., Rigazio, A., Burden, A., & Thomas, M.
- Venue
- Journal of Asthma and Allergy
- Publisher
- Informa UK Limited
- Published
- 2016-01
- Volume
- 9
- Pages
- 1
- ISSN
- 1178-6965 (ISSN-L)
- OpenAlex
- W2230116493
- Cited by
- 203
- References
- 0
- FWCI
- 20.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.